Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.46%
SPX
+0.32%
IXIC
+0.96%
FTSE
+0.41%
N225
-0.88%
AXJO
-1.82%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
72.75M
Dividend Yield
0.00%
P/E Ratio
-1.48
EPS
-1.31
Revenue
-
Avg. Volume
136.06K

Recently from Cashu

publisher logo
Cashu

Quince Therapeutics: Harnessing Historical Unity to Overcome Modern Biotech Challenges

5 days ago
publisher logo
Cashu

Quince Therapeutics Joins Zifo Open Quiz Celebrating Knowledge and Diversity in Chennai

12 days ago
publisher logo
Cashu

Quince Therapeutics: Cornerstone Research Promotes Leaders to Strengthen Economic Consulting Services

16 days ago

About

What does QNCX do?
Quince Therapeutics, based in South San Francisco, develops therapeutics using its AIDE technology to encapsulate drugs in patients' red blood cells, targeting rare diseases like Ataxia-Telangiectasia. The company went public on May 9, 2019, and employs 32 people.
Sector
💻 Health Care
IPO
CEO
Employees
36
Headquarters
California, USA
Website
http://www.cortexyme.com
Stocks
Health Care
qncx
Quince Therapeutics
NASDAQ: QNCX
-0.03 (0.00%)
1.57
USD
At close at Sep 03, 13:26 UTC
Summary
News
Signals
Benchmarks
Financials